Skip to main content

ERRATUM article

Front. Oncol., 18 July 2019
Sec. Cancer Molecular Targets and Therapeutics
Volume 9 - 2019 | https://doi.org/10.3389/fonc.2019.00709

Erratum: ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

This article is an erratum on:

  1. ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

    1. Read original article
\n Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

by La Ferla, M., Lessi, F., Aretini, P., Pellegrini, D., Franceschi, S., Tantillo, E., et al. (2019). Front. Oncol. 9:547. doi: 10.3389/fonc.2019.00547

Due to a production error, the affiliation for Antonio G. Naccarato was incorrectly given as the “Department of Cell and Developmental Biology, the Hebrew University of Jerusalem, Jerusalem, Israel” (affiliation 8). The correct affiliation is the “Department of Translational Research and New Technologies in Medicine and Surgery, University Hospital of Pisa, Pisa, Italy” (affiliation 10).

The publisher apologizes for this mistake. The original article has been updated.

Keywords: Her2+ breast cancer, Trastuzumab resistance, ANKRD44, next generation sequencing, LC-MS/MS, gene silencing

Citation: Frontiers Production Office (2019) Erratum: ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer. Front. Oncol. 9:709. doi: 10.3389/fonc.2019.00709

Received: 16 July 2019; Accepted: 16 July 2019;
Published: 18 July 2019.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.